US 8552198
Benzimidazole compound crystal
granted A61KA61K31/4439A61P
Quick answer
US patent 8552198 (Benzimidazole compound crystal) held by Takeda Pharmaceutical Company Limited expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/4439, A61P, A61P1/00, A61P1/04